Stem cells – what is the evidence: Currently licensed products in the UK: Arte Cell
Arte Cell
Published 26 February 2024
Arte Cell includes chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells and is indicated for the “Reduction of mild to moderate recurrent lameness associated with non-septic joint inflammation in horses”.
Veterinary Medicines Directorate (2023) Summary of Product Characteristics: Arte Cell Forte suspension for injection for horses. Available from: https://www.vmd.defra.gov.uk/ProductInformationDatabase/files/SPC_Documents/SPC_2223841.PDF [Accessed 23 February 2024]
- Broeckx, S.Y. et al. (2019) The use of equine chondrogenic‐induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double‐blinded, placebo‐controlled proof‐of‐concept study. Equine Veterinary Journal, 51 (6), pp. 787-794. https://doi.org/10.1111/evj.13089
- Coomer, R.P. et al. (2024) Allogeneic chondrogenic‐induced mesenchymal stem cells for the treatment of tarsometatarsal lameness in horses. Veterinary Surgery, 53 (1), pp. 175-183. https://doi.org/10.1111/vsu.14030
Claiming CPD for reading inFOCUS articles
Reading and reflecting on articles can count towards your CPD, and we have a template to help you with the process.
Online full-text available to Library members
A range of library membership packages is available and MRCVS vets and RVNs can join the library for a heavily subsidised, annual fee.
Leave a Reply
Want to join the discussion?Feel free to contribute!